丹红注射液治疗40例肝硬化的疗效观察  

Effective observation on treating 40 cases of cirrhosis with Danhong injection

作　　者：蔡宝玲 朱铁兵[2] 徐丰[2] 邹冬侠 

机构地区：[1]江苏省宿迁市卫生学校,江苏宿迁223800 [2]江苏省宿迁市宿城区人民医院,江苏宿迁223800

出　　处：《中医临床研究》2010年第23期101-103,共3页Clinical Journal Of Chinese Medicine

摘　　要：目的：观察丹红注射液对肝硬化病人的治疗效果。方法：对照组38例，以甘利欣、Vitc、肌苷静脉滴注，每天一次口服水飞蓟素，两组疗程均为4周。治疗组40例，在对照组治疗基础上予丹红注射液40ml加入250ml葡萄糖注射液中稀释后缓慢滴注，每天一次；观察肝功能、肝纤维化及血流变的变化。结果：治疗组与对照组比较，总有效率有显著差异（P〈0．05）；胆红素和转氨酶复常方面，治疗组亦优于对照级，有显著差异（P〈0．05）；两组治疗前后肝纤维化指标检测结果，治疗组与对照组治疗后比较有显著差异（P〈O．05）：两组治疗前后血流变检测结果，治疗组与对照组治疗后比较部分项目有显著差异（P〈0．05、P〈0．01）。结论：丹红注射液对肝功能、肝纤维化及部分血流变项目有改善。Objective： To observe the protective effect of Danhong injection on patients with liver cirrhosis. Method： 78 patients with liver cirrhosis were randomly divided into treatment group （n=40） and control group （n=38）. The treatment group were given Danhong Zhusheye injection. While, the control group was treated with Diammonium Glycyrrhizinate injection, Vitamin C injection, Inosine inject -tion and silymarin once a day. The two groups were observed 4weeks. Results： As compared to control group, the treatment group had a more significant improvement in clinical symptoms and liver function （P〈0.05）.There were also significant differences of the indicator of liver fibrosis and hemorheology of the treatment group than that of the control group （P〈0.05）. Conclusion： Danhong injection can result in a significant improvement of liver function, liver fibrosis and some indicator of hemorheology.

关 键 词：丹红注射液 肝硬化 肝纤维化 血流变 

分 类 号：R657.31[医药卫生—外科学]